azacitidine and Gangliocytoma

azacitidine has been researched along with Gangliocytoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allemanni, G; Banelli, B; Bonassi, S; Borzì, L; Brigati, C; Casciano, I; Di Vinci, A; Mazzocco, K; Romani, M; Scaruffi, P; Tonini, GP	1
Clark, GJ; Ekström, TJ; Farnebo, F; Geli, J; Juhlin, C; Kiss, N; Kogner, P; Lanner, F; Larsson, C; Natalishvili, N	1

Other Studies

2 other study(ies) available for azacitidine and Gangliocytoma

Article	Year
Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients. International journal of cancer, 2010, Feb-01, Volume: 126, Issue:3 Topics: 14-3-3 Proteins; Azacitidine; Biomarkers, Tumor; Cell Line, Tumor; Child; Child, Preschool; Cohort Studies; CpG Islands; DNA Methylation; DNA, Neoplasm; Exonucleases; Exoribonucleases; Female; Ganglioneuroblastoma; Ganglioneuroma; Humans; Infant; Kaplan-Meier Estimate; Male; Neoplasm Proteins; Neuroblastoma; Prognosis; Proportional Hazards Models; Risk; Risk Assessment; Sequence Analysis, DNA; Soft Tissue Neoplasms; Survivors	2010
Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma. International journal of cancer, 2008, Jul-15, Volume: 123, Issue:2 Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Bromodeoxyuridine; Cell Line, Tumor; DNA Methylation; Down-Regulation; Ganglioneuroma; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Hydroxamic Acids; Monomeric GTP-Binding Proteins; Neuroblastoma; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger	2008

Article

Year

Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients.

International journal of cancer, 2010, Feb-01, Volume: 126, Issue:3

Topics: 14-3-3 Proteins; Azacitidine; Biomarkers, Tumor; Cell Line, Tumor; Child; Child, Preschool; Cohort Studies; CpG Islands; DNA Methylation; DNA, Neoplasm; Exonucleases; Exoribonucleases; Female; Ganglioneuroblastoma; Ganglioneuroma; Humans; Infant; Kaplan-Meier Estimate; Male; Neoplasm Proteins; Neuroblastoma; Prognosis; Proportional Hazards Models; Risk; Risk Assessment; Sequence Analysis, DNA; Soft Tissue Neoplasms; Survivors

2010

Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma.

International journal of cancer, 2008, Jul-15, Volume: 123, Issue:2

Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Bromodeoxyuridine; Cell Line, Tumor; DNA Methylation; Down-Regulation; Ganglioneuroma; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Hydroxamic Acids; Monomeric GTP-Binding Proteins; Neuroblastoma; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2008